NCT04191369

Brief Summary

Liver cirrhosis with the further development of portal hypertension implies structural and vasculature alteration in the portosplenic circulation. Esophagogastroduodenoscopy is the standard of care for the detection and treatment of esophageal varices, as esophageal varices serve as a surrogate for estimating a portal pressure gradient \> 10 mmHG. Endoscopic ultrasound evaluation allows the detection of peri-esophageal collateral veins, perforating veins and para-esophageal collateral veins, which has demonstrated to be effective for the prediction of esophageal varices recurrence after variceal eradication. The investigators aimed to compare esophagogastroduodenoscopy versus endoscopic ultrasound evaluation for the early diagnosis of portal hypertension in cirrhotic patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 9, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

December 9, 2019

Status Verified

December 1, 2019

Enrollment Period

1 year

First QC Date

November 7, 2019

Last Update Submit

December 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of portal hypertension

    Portal hypertension diagnosis based on portal pressure gradient

    During portal pressure gradient meassurement up to 4 weeks after randomization

Secondary Outcomes (2)

  • diagnostic accuracy of esophagogastroduodenoscopy

    during esophagogastroduodenoscopy procedure up to 2 weeks after randomization

  • diagnostic accuracy of endoscopic ultrasound

    during endoscopic ultrasound evaluation up yo 2 weeks after randomization

Study Arms (2)

EGD evaluation

PLACEBO COMPARATOR

Esophogagastroduodenoscopy for the evaluation of esophageal varices, gastric varices and hypertensive gastropathy. Portal pressure gradient will be evaluated via interventional radiology as gold standard.

Diagnostic Test: Esophagogastroduodenoscopy

EUS evaluation

EXPERIMENTAL

Endoscopic ultrasound evaluation for the presence of esophageal varices, peri and para-esophageal collateral veins, gastric varices, portal hypertensive gastropathy, azygos vein diameter, blood flow and BFVI. Portal pressure gradient will be evaluated via interventional radiology as gold standard.

Diagnostic Test: Endoscopic ultrasound

Interventions

Esophogagastroduodenoscopy for the evaluation of esophageal varices, gastric varices and hypertensive gastropathy. Portal pressure gradient will be evaluated via interventional radiology as gold standard.

EGD evaluation
Endoscopic ultrasoundDIAGNOSTIC_TEST

Endoscopic ultrasound evaluation for the presence of esophageal varices, peri and para-esophageal collateral veins, gastric varices, portal hypertensive gastropathy, azygos vein diameter, blood flow and BFVI. Portal pressure gradient will be evaluated via interventional radiology as gold standard.

EUS evaluation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Above 18 years old
  • Willingness to participate in the study
  • Compensated liver cirrhosis based on clinical and imaging findings
  • Written informed consent provided

You may not qualify if:

  • Decompensated liver cirrhosis: ascitis, encephalopathy, gastrointestinal bleeding, infection
  • Hemodynamic instability
  • Pregant or nursing patients
  • Patients with history of esophageal, gastric, liver, pancreas and spleen tumors
  • Severe uncontrolled coagulopathy
  • Any contraindication for portal pressure gradient meassurement via radiological evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ecuadorian Institute of Digestive Diseases

Guayaquil, Guayas, 090505, Ecuador

RECRUITING

Related Publications (2)

  • Boustiere C, Dumas O, Jouffre C, Letard JC, Patouillard B, Etaix JP, Barthelemy C, Audigier JC. Endoscopic ultrasonography classification of gastric varices in patients with cirrhosis. Comparison with endoscopic findings. J Hepatol. 1993 Sep;19(2):268-72. doi: 10.1016/s0168-8278(05)80581-1.

    PMID: 8301060BACKGROUND
  • Hammoud GM, Ibdah JA. Utility of endoscopic ultrasound in patients with portal hypertension. World J Gastroenterol. 2014 Oct 21;20(39):14230-6. doi: 10.3748/wjg.v20.i39.14230.

    PMID: 25339809BACKGROUND

MeSH Terms

Conditions

Hypertension, Portal

Interventions

Endoscopy, Digestive SystemEndosonography

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresUltrasonographyDiagnostic Imaging

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2019

First Posted

December 9, 2019

Study Start

November 1, 2019

Primary Completion

November 1, 2020

Study Completion

November 30, 2020

Last Updated

December 9, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations